Shareholder Forum for Options Policies

Forum Home Page

Options Policies Home Page

Program Reference


For news reports of analyst and governance expert reactions to the Pfizer plan announced in the press release below, see

For the responsive advice of corporate lawyers, see

For subsequent reports of the meeting and of the evolving position of one of the lawyers, see

Note: Pfizer has been represented on the Forum Advisory Panel that defined principles for shared management and investor interests in compensation practices, including the exchange of information needed by decision-makers; the editor of Global Proxy Watch, Stephen M. Davis, has been preparing research papers for the Yale University Millstein Center for Corporate Governance relating to that Forum program's project addressing advisory voting and to the broader applications of its shareholder communication processes.


Pfizer, Inc., June 28, 2007 press release


Pfizer Board of Directors to Initiate Face-to-Face Meetings with Company’s Institutional Investors on Corporate Governance Policies and Practices

Commitment Enhances Long-Standing Focus on Highest Governance Standards

NEW YORK--(BUSINESS WIRE)--Pfizer said today that members of its Board of Directors will invite its largest institutional shareholders to a meeting where they will have an opportunity to provide comments and perspective on the company’s governance policies and practices including executive compensation.

Pfizer is the first company to initiate a regular meeting between its Board and institutional investors on governance. The Board will invite representatives who evaluate governance practices and who vote the proxies of the company’s largest institutional investors. These representatives own in aggregate approximately 35 percent of Pfizer’s shares. The initial meeting is planned for the fall.

“We believe this meeting with our shareholders on our governance and compensation policies will give us valuable insights and help us maintain the highest standards in corporate governance,” said Constance Horner, Lead Director of the Pfizer Board. “I am personally committed as the Chair of the Governance Committee, as are the Chairs of the Compensation and Audit Committees, to attend these meetings and listen to shareholder viewpoints on governance and executive compensation."

The Pfizer Board has in place several other mechanisms to foster communications with all shareholders. These include e-mail addresses for the Lead Director and committee chairs and a Board policy of regularly reviewing communications that it receives from shareholders. In addition, members of the Board regularly participate in investor conferences focused on governance practices.

Said Dana Mead, Chairman of the Compensation Committee, “The opinions of our shareholders have always been important to the Board. Today’s announcement builds on our broad-based outreach to shareholders and formalizes what we have informally practiced for many years.”

Pfizer has been in the forefront of corporate governance for over two decades. It has taken the lead in the elimination of its poison pill; the declassification of the Board, so that all directors are elected at each annual meeting; the adoption of majority voting policy; and expanded disclosures on executive compensation well ahead of new SEC regulations. The company was also among the first to use SEC “Plain English” rules to make disclosures more understandable to investors.

“Open and candid dialogue with our shareholders -- and, in fact, all of our stakeholders – is very valuable and will help us become a better company,” said Pfizer’s Chairman and Chief Executive Officer, Jeff Kindler. “These meetings reflect the view of both Pfizer’s management and its Board that we must listen to shareholder viewpoints on governance so that we can continue to improve our practices.”

Andy McCormick, 212-733-5469


 © Business Wire 2007




This Forum program is open, free of charge, to all shareholders of the invited corporate participants, and to any fiduciaries or professionals concerned with the investment decisions of those shareholders, according to the posted Conditions of Participation.  The Forum's purpose is to provide shareholders with access to information and a free exchange of views on issues relating to their investment interests described in the Forum Summary As stated in the Conditions, all Forum participants are expected to make independent use of information obtained through the Forum, subject to the privacy rights of other participants.  It is a Forum rule that participants will not be identified or quoted without their explicit permission.

This Forum program has been organized with the support of Hermes Equity Ownership Services, Ltd.  It is the first in an expected series that will be managed by a not-for-profit “Institute” to be established for the purpose of continuing the Forum programs conducted by Gary Lutin.

Inquiries and requests to be included in the Forum's distribution list may be addressed to  The information provided to Forum participants is intended for their private reference, and permission has not been granted for the republishing of any copyrighted material.

All material on this web site is published by Gary Lutin, who is responsible for conducting the Forum.